Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine oropharyngeal spray before tracheal intubation in CABG patients
IRCT20170411033365N3Phase 2Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of lidocaine in coronary arteriosclerosis, sponsored by Urmia University of Medical Sciences. Primary endpoints: Heart rate during and after tracheal intubation, Blood pressure during and after tracheal intubation and 1 more. Started Apr 2022; status: completed.
02
Drugs
lidocaine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20170411033365N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170411033365N3.